Related Experiment Video

Updated: Dec 19, 2025

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

688

COVID-19 and Its Potential Effect on Patients With Rheumatic Diseases in Latin America

Claudia Elera-Fitzcarrald1, Manuel F Ugarte-Gil, Graciela S Alarcón

  • 1From the Facultad de Medicina, Universidad Científica del Sur.

Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|June 9, 2020
PubMed

Insights

The COVID-19 pandemic disproportionately impacts Latin America's vulnerable populations, including rheumatic disease patients. Strategies like telemedicine and protective measures are crucial for managing rheumatic conditions during the pandemic.

Area of Science:

  • Rheumatology
  • Infectious Diseases
  • Public Health

Background:

  • The COVID-19 pandemic presents unique challenges for global health, particularly in regions with healthcare disparities like Latin America.
  • Patients with rheumatic diseases are at increased risk for severe COVID-19 outcomes due to their chronic conditions and potential immunosuppression.
  • Antimalarial drug overuse for COVID-19 treatment poses a risk of regional shortages, impacting rheumatic disease management.

Purpose of the Study:

  • To highlight the heightened vulnerability of rheumatic disease patients in Latin America during the COVID-19 pandemic.
  • To discuss the potential impact of COVID-19 treatments on medication availability for rheumatic conditions.
  • To propose strategies for mitigating risks and improving care for rheumatic disease patients amidst the pandemic.

Main Methods:

  • Review of the impact of COVID-19 on healthcare access and patient populations in Latin America.
  • Analysis of the risks associated with COVID-19 treatment on antimalarial drug availability.
  • Identification of key interventions for managing rheumatic diseases during a pandemic.

Main Results:

  • Latin American populations, especially those with rheumatic diseases, face severe risks from COVID-19 due to poverty and healthcare deficits.
  • Potential shortages of antimalarials due to COVID-19 treatment overuse could compromise care for rheumatic conditions.
  • Telemedicine, personal protective equipment, and comprehensive care models are identified as essential tools.

Conclusions:

  • Implementing telemedicine, protective measures, and comprehensive care is vital for safeguarding rheumatic disease patients during the COVID-19 pandemic.
  • Enhanced knowledge sharing and adoption of these strategies can improve rheumatologist expertise globally.
  • Proactive management is necessary to address the intersecting challenges of infectious disease pandemics and chronic condition care.

More Related Videos

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

856

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
204
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
322
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
189
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
321
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
110
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
198